Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)

6.88
Delayed Data
As of May 22
 +0.08 / +1.18%
Today’s Change
4.36
Today|||52-Week Range
7.09
+15.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$115.8M

Company Description

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is focused on the acquisition, development and commercialization of branded prescription products. The company's primary target markets include hospital acute care and gastroenterology. Its products include Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose (lactulose) for Oral Solution, a prescription laxative. Cumberland Pharmaceuticals was founded by A. J. Kazimi in 1999 and is headquartered in Nashville, TN.

Contact Information

Cumberland Pharmaceuticals, Inc.
2525 West End Avenue
Nashville Tennessee 37203
P:(615) 255-0068
Investor Relations:

Employees

Shareholders

Mutual fund holders7.92%
Individual stakeholders45.56%
Other institutional25.40%

Top Executives

A. J. KazimiChairman & Chief Executive Officer
Leo PavlivChief Development Officer & Senior VP-Operations
Rick Scott GreeneChief Financial Officer, VP-Finance & Accounting
Amy Dix RockSenior Director-Regulatory & Scientific Affairs
Arthur P. WheelerDirector-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account